Timothy M Mayleben is of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 24,375 shares of MRNS, which is worth approximately $7,800. The most recent transaction as insider was on Jun 18, 2024, when has been sold 2,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K
0% 3M change
39.48% 12M change
Total Value Held $7,800

TIMOTHY M MAYLEBEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Grant, award, or other acquisition
-
2,300 Added 8.62%
24,375 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
4,600 Added 17.24%
22,075 Common Stock
Jan 26 2023
BUY
Grant, award, or other acquisition
-
3,600 Added 17.08%
17,475 Common Stock
Feb 04 2022
BUY
Grant, award, or other acquisition
-
2,750 Added 16.54%
13,875 Common Stock

Also insider at

ESPR
Esperion Therapeutics, Inc. Healthcare
LABP
Landos Biopharma, Inc. Healthcare
TMM

Timothy M Mayleben

Ann Arbor, MI

Track Institutional and Insider Activities on MRNS

Follow MARINUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNS shares.

Notify only if

Insider Trading

Get notified when an Marinus Pharmaceuticals, Inc. insider buys or sells MRNS shares.

Notify only if

News

Receive news related to MARINUS PHARMACEUTICALS, INC.

Track Activities on MRNS